News from otonomy, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Jul 14, 2014, 07:30 ET
Otonomy, Inc. Logo.  (PRNewsFoto/Otonomy, Inc.)

Otonomy Files Registration Statement for Proposed Initial Public Offering

 Otonomy, Inc., a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics for...

Jul 08, 2014, 07:30 ET
Otonomy, Inc. Logo.  (PRNewsFoto/Otonomy, Inc.)

Otonomy Announces Positive Results from Two Phase 3 Trials of AuriPro™ in Pediatric Patients Undergoing Ear Tube Placement Surgery

 Otonomy, Inc., a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics for...

May 08, 2014, 07:30 ET
Otonomy, Inc. Logo.  (PRNewsFoto/Otonomy, Inc.)

Otonomy Completes Enrollment of AuriPro™ Pivotal Studies in Pediatric Patients Undergoing Ear Tube Placement Surgery

 Otonomy, Inc., a biopharmaceutical company developing and commercializing innovative therapeutics for diseases and disorders of the inner...

Apr 30, 2014, 07:30 ET
Otonomy, Inc. Logo.  (PRNewsFoto/Otonomy, Inc.)

Otonomy Raises $49 Million in Oversubscribed Financing

 Otonomy, Inc., a biopharmaceutical company developing and commercializing innovative therapeutics for diseases and disorders of the inner and...

Mar 20, 2014, 08:00 ET
Otonomy, Inc. Logo.  (PRNewsFoto/Otonomy, Inc.)

Otonomy Appoints Vickie Capps to Board of Directors

 Otonomy, Inc., a clinical stage biopharmaceutical company developing innovative therapeutics for diseases and disorders of the inner and...

Feb 25, 2014, 08:00 ET
Otonomy, Inc. Logo.  (PRNewsFoto/Otonomy, Inc.)

Otonomy Appoints Robert Savel as Chief Technical Officer

 Otonomy, Inc., a clinical stage biopharmaceutical company developing innovative therapeutics for diseases and disorders of the inner and...

Dec 11, 2013, 07:30 ET
Otonomy, Inc. Logo.  (PRNewsFoto/Otonomy, Inc.)

Otonomy Enrolls First Patient in Pivotal Phase 2b Study of OTO-104 in Meniere's Disease

Otonomy, Inc., a clinical stage biopharmaceutical company developing innovative therapeutics for diseases and disorders of the inner and middle...

Dec 11, 2013, 07:30 ET
Otonomy, Inc. Logo.  (PRNewsFoto/Otonomy, Inc.)

Otonomy Doses First Subjects in Phase 3 Clinical Trials of OTO-201 in Pediatric Patients Undergoing Ear Tube Placement Surgery

Otonomy, Inc., a clinical stage biopharmaceutical company developing innovative therapeutics for diseases and disorders of the inner and middle...

Oct 31, 2013, 07:30 ET
Otonomy, Inc. Logo.  (PRNewsFoto/Otonomy, Inc.)

Otonomy Acquires Assets and Patent Rights for Tinnitus Program

 Otonomy, Inc., a clinical stage biopharmaceutical company developing innovative therapeutics for diseases and disorders of the inner and...

Sep 04, 2013, 07:30 ET
Otonomy, Inc. Logo.  (PRNewsFoto/Otonomy, Inc.)

Otonomy Completes $45.9 Million Series C Equity Financing

Otonomy, Inc., a clinical stage biopharmaceutical company developing innovative therapeutics for diseases and disorders of the inner and middle...

Aug 20, 2013, 07:30 ET
Otonomy, Inc. Logo.  (PRNewsFoto/Otonomy, Inc.)

Otonomy Announces Positive Phase 1b Results for OTO-201 in Pediatric Patients Undergoing Ear Tube Placement Surgery

 Otonomy, Inc., a clinical stage biopharmaceutical company developing innovative therapeutics for diseases and disorders of the inner and...

Sep 29, 2011, 07:30 ET

Otonomy Presents Positive New Findings From Phase 1b Study of OTO-104 in Meniere's Disease at International Conference

Otonomy, Inc., a clinical stage biopharmaceutical company developing innovative therapeutics for diseases and disorders of the inner and middle...

Jun 08, 2011, 07:30 ET

Otonomy Announces Preclinical Results Supporting Intra-operative Use of OTO-201 for Common Childhood Procedure

Otonomy, Inc., a developer of innovative therapeutics for diseases and disorders of the ear, today announced positive results for OTO-201, a...

May 25, 2011, 07:30 ET

Otonomy Appoints Gerald Wroblewski as Chief Operations Officer

Otonomy, Inc., a clinical stage biopharmaceutical company developing innovative therapeutics for diseases and disorders of the inner and middle...

Apr 28, 2011, 07:30 ET

Otonomy Announces Positive Results from Phase 1b Study of OTO-104 in Meniere's Disease

Otonomy, Inc., a clinical stage biopharmaceutical company developing innovative therapeutics for diseases and disorders of the inner and middle...

Feb 22, 2011, 07:30 ET

Otonomy's OTO-104 Demonstrates Hearing Loss Protection and Hearing Recovery in Preclinical Studies

Otonomy, Inc., a developer of innovative therapeutics for diseases and disorders of the ear, today announced positive results for the company's...

Feb 03, 2011, 07:30 ET

Otonomy Adds Key Product and Industry Experience with Appointment of New Vice Presidents

Otonomy, Inc., a developer of innovative therapeutics for disorders of the ear, today announced the appointments of G. Michael Wall, Ph.D., as the...

Dec 08, 2010, 08:00 ET

Otonomy Appoints David A. Weber, Ph.D., Chief Executive Officer

Otonomy, Inc. announced today that David A. Weber, Ph.D., has joined the company as president, CEO and member of the Board of Directors. Jay...

Aug 30, 2010, 08:00 ET

Otonomy Closes $38.5 Million Series B Financing

Otonomy, Inc. announced today that it has closed a $38.5 million Series B financing co-led by Novo Ventures and RiverVest Venture Partners, and...

Jun 11, 2010, 08:00 ET

Otonomy Closes $10 Million Series A Financing

Otonomy, Inc. announced today that it has completed a $10 million Series A financing with Avalon Ventures. Proceeds from the financing will be used...